Benzinga | Aug 31, 2021 07:32AM EDT

Morgan Stanley Maintains Overweight on CVS Health, Raises Price Target to $114

Morgan Stanley analyst Craig Hettenbach maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $99 to $114.